Literature DB >> 4091041

The determination of glial fibrillary acidic protein for the diagnosis and histogenetic study of central nervous system tumors: a study of 152 cases.

K Hamaya, K Doi, T Tanaka, A Nishimoto.   

Abstract

Glial fibrillary acidic protein (GFAP) was purified from human spinal cord and cerebral white matter. GFAP was localized by an immuno-peroxidase method in normal adult and fetal human brains, rat brains, and 152 central nervous system (CNS) tumors. GFAP was found in reactive and normal astrocytes, immature cells of fetal brain at the 18th to 21st gestational weeks, and normal rat astrocytes. This GFAP staining was quite specific for glial tumors, including astrocytomas, glioblastomas, astroblastomas, and ependymomas. GFAP-positive cells were also found in oligodendrogliomas and choroid plexus papillomas, and they were interpreted as being astroglial or ependymal differentiations. Stromal cells in cerebellar hemangioblastomas were negative. However, engulfed astrocytes were found at the periphery of such tumors and often adjacent to the proliferate blood vessels. In meningiomas, neurinomas, metastatic carcinomas, pituitary adenomas and other non-glial tumors, GFAP-positive cells were not identified.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4091041     DOI: 10.18926/AMO/31509

Source DB:  PubMed          Journal:  Acta Med Okayama        ISSN: 0386-300X            Impact factor:   0.892


  9 in total

1.  Exploratory investigation of eight circulating plasma markers in brain tumor patients.

Authors:  Aysegul Ilhan-Mutlu; Ludwig Wagner; Georg Widhalm; Adelheid Wöhrer; Sophie Bartsch; Thomas Czech; Harald Heinzl; Fritz Leutmezer; Daniela Prayer; Christine Marosi; Wolfgang Base; Matthias Preusser
Journal:  Neurosurg Rev       Date:  2012-07-05       Impact factor: 3.042

2.  Efficient chemotherapy of rat glioblastoma using doxorubicin-loaded PLGA nanoparticles with different stabilizers.

Authors:  Stefanie Wohlfart; Alexander S Khalansky; Svetlana Gelperina; Olga Maksimenko; Christian Bernreuther; Markus Glatzel; Jörg Kreuter
Journal:  PLoS One       Date:  2011-05-06       Impact factor: 3.240

3.  Glioblastoma stem cells (GSCs) epigenetic plasticity and interconversion between differentiated non-GSCs and GSCs.

Authors:  Ahmad R Safa; Mohammad Reza Saadatzadeh; Aaron A Cohen-Gadol; Karen E Pollok; Khadijeh Bijangi-Vishehsaraei
Journal:  Genes Dis       Date:  2015-06

Review 4.  The good, the bad and the ugly: epigenetic mechanisms in glioblastoma.

Authors:  Helena Carén; Steven M Pollard; Stephan Beck
Journal:  Mol Aspects Med       Date:  2012-07-04

Review 5.  Contribution of the Microenvironmental Niche to Glioblastoma Heterogeneity.

Authors:  Ivy A W Ho; Winston S N Shim
Journal:  Biomed Res Int       Date:  2017-05-28       Impact factor: 3.411

6.  Sustained NF-κB-STAT3 signaling promotes resistance to Smac mimetics in Glioma stem-like cells but creates a vulnerability to EZH2 inhibition.

Authors:  Bakhos A Tannous; Christian E Badr; Cintia Carla da Hora; Kelsey Pinkham; Litia Carvalho; Max Zinter; Elie Tabet; Ichiro Nakano
Journal:  Cell Death Discov       Date:  2019-03-04

7.  Stimulation of glioma cell motility by expression, proteolysis, and release of the L1 neural cell recognition molecule.

Authors:  Muhua Yang; Shalini Adla; Murali K Temburni; Vivek P Patel; Errin L Lagow; Owen A Brady; Jing Tian; Magdy I Boulos; Deni S Galileo
Journal:  Cancer Cell Int       Date:  2009-10-29       Impact factor: 5.722

Review 8.  Cancer Stem Cell Hierarchy in Glioblastoma Multiforme.

Authors:  Amy Bradshaw; Agadha Wickremsekera; Swee T Tan; Lifeng Peng; Paul F Davis; Tinte Itinteang
Journal:  Front Surg       Date:  2016-04-15

9.  Emerging targets for glioblastoma stem cell therapy.

Authors:  Ahmad R Safa; Mohammad Reza Saadatzadeh; Aaron A Cohen-Gadol; Karen E Pollok; Khadijeh Bijangi-Vishehsaraei
Journal:  J Biomed Res       Date:  2015-09-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.